Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

Research output: Contribution to journalJournal articleResearchpeer-review

  • Mona Aarenstrup Karlsen
  • Noreen Sandhu
  • Høgdall, Claus Kim
  • Ib Jarle Christensen
  • Lotte Nedergaard
  • Lene Lundvall
  • Svend A Engelholm
  • Pedersen, Anette Tønnes
  • Dorthe Hartwell
  • Magnus Christian Lydolph
  • Inga Alice Laursen
  • Estrid V S Høgdall
Diagnostic factors are needed to improve the currently used serum CA125 and risk of malignancy index (RMI) in differentiating ovarian cancer (OC) from other pelvic masses, thereby achieving precise and fast referral to a tertiary center and correct selection for further diagnostics. The aim was to evaluate serum Human Epididymis protein 4 (HE4) and the risk of ovarian malignancy algorithm (ROMA) for these purposes.
Original languageEnglish
JournalGynecologic Oncology
Issue number2
Pages (from-to)379-83
Number of pages5
Publication statusPublished - 2012

ID: 48443576